Pentopril-cimetidine interaction caused by a reduction in hepatic blood flow

J Clin Pharmacol. 1988 Mar;28(3):222-7. doi: 10.1002/j.1552-4604.1988.tb03136.x.

Abstract

The interactive effects of the coadministration of steady-state cimetidine and single-dose pentopril, an angiotensin converting enzyme inhibitor, on the pharmacokinetic disposition of each other were studied in humans. Cimetidine reduced the clearance of pentopril by 11 to 14%. This reduction in clearance was shown to be caused by a reduction in liver blood flow probably mediated through H2 receptor blockade. Meanwhile pentopril induced the oral clearance of cimetidine by 21%, presumably by a reduction in the bioavailable fraction of cimetidine. The mechanism of this interaction is unknown.

MeSH terms

  • Administration, Oral
  • Adult
  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage
  • Angiotensin-Converting Enzyme Inhibitors / pharmacokinetics*
  • Animals
  • Cimetidine / administration & dosage
  • Cimetidine / metabolism
  • Cimetidine / pharmacokinetics*
  • Drug Interactions
  • Drug Therapy, Combination
  • Humans
  • Indoles / administration & dosage
  • Indoles / metabolism
  • Indoles / pharmacokinetics*
  • Liver / blood supply*
  • Liver / drug effects
  • Liver / metabolism
  • Male
  • Random Allocation
  • Rats
  • Rats, Inbred Strains
  • Regional Blood Flow / drug effects

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Indoles
  • Cimetidine
  • CGS 13945